Immune cell profiling and proteomic analyses have demonstrated that inhibiting fascin expression in intratumoral DCs enhances antigen uptake and increases immune cell presence, suggesting that suppressing fascin activity contributes to tumor inhibition within the tumor microenvironment [37]. The gene discussed is FSCN1; the disease is neoplasm.